TY - JOUR
T1 - Seroepidemiology of parechovirus A3 neutralizing antibodies, Australia, The Netherlands, and United States
AU - Karelehto, Eveliina
AU - Brouwer, Lieke
AU - Benschop, Kimberley
AU - Kok, Jen
AU - Basile, Kerri
AU - McMullan, Brendan
AU - Rawlinson, William
AU - Druce, Julian
AU - Nicholson, Suellen
AU - Selvarangan, Rangaraj
AU - Harrison, Christopher
AU - Lankachandra, Kamani
AU - van Eijk, Hetty
AU - Koen, Gerrit
AU - de Jong, Menno
AU - Pajkrt, Dasja
AU - Wolthers, Katja C.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
AB - Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058752511&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30561318
U2 - 10.3201/eid2501.180352
DO - 10.3201/eid2501.180352
M3 - Article
C2 - 30561318
SN - 1080-6040
VL - 25
SP - 148
EP - 152
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 1
ER -